Abstract
Elements of the endocannabinoid system (ECS) are expressed by islet endocrine cells and activation of CB1 and CB2 cannabinoid receptors regulates insulin secretion from mouse and human beta-cells. The current study aimed to investigate the expression and function, in mouse and human beta-cells, of monoacylglycerol lipase (MGL), an enzyme that facilitates degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG). We found that MGL mRNA is expressed by MIN6 beta-cells, mouse islets, human islets and enriched human islet beta-cells, and immunohistochemistry indicated that MGL localisation in human islets is consistent with its expression by some beta- and - alpha-cells. Blockade of MGL activity with the pharmacological inhibitor URB602 led to increased [Ca2+](i) and enhanced insulin secretion from MIN6 beta-cells, and MGL inhibition also elevated insulin and glucagon secretion from isolated human islets in vitro. These data imply a stimulatory role for endogenous 2-AG in islets that is amplified when its degradation is blocked. Copyright (C) 2012 S. Karger AG, Basel
Original language | English |
---|---|
Pages (from-to) | 347-358 |
Number of pages | 12 |
Journal | Cellular Physiology and Biochemistry |
Volume | 30 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jul 2012 |